Sponsored Links

NICE Recommends Topotecan For Cervical Cancer PDF Print E-mail
Medical News - Cervical Cancer HPV
The National Institute for Health and Clinical Excellence (NICE) has today (28 October) published final guidance recommending the use of topotecan in combination with cisplatin as a treatment option for women with recurrent or stage IVB cervical cancer who have not previously received cisplatin.

Read more: Cervical Cancer / HPV Vaccine News From Medical News Today